In December 1996, Sandoz and Ciba-Geigy merged to form Novartis in one of the largest corporate mergers in history. Sandoz remained as a subsidiary of Novartis and today develops, manufactures and ...

Novartis has a lot cooking with new drug launches, and the company is not letting potential U.S. tariffs on pharmaceuticals ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...

This risk is higher in a company without a history of growth. You can see Novartis' historic earnings and revenue below, but keep in mind there's always more to the story. SWX:NOVN Earnings and ...

But Novartis stock climbed 1.4% to close at 112.26 as Travere stock fell 7.7%, closing at 16.56. There's a long history behind atrasentan, the drug that became Vanrafia. It's an endothelin A ...

The US is a priority market for Novartis, and the company has taken numerous steps over its 200-year history to build its US infrastructure. Over the next 5 years, the total investment in ...

Amid renewed threats of import tariffs on pharmaceuticals from the Trump administration, Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and ...